S0137 Didanosine (ddi), 25 mg

Billable / valid for submission HCPCS Release 2026Q3

Short description: Didanosine, 25 mg

Version history

Release	Valid from	Valid to	Description	Billable
2026Q3	2026-07-01	current	Didanosine (ddi), 25 mg	yes

S0104 Zidovudine, oral, 100 mg
S0106 Bupropion hcl sustained release tablet, 150 mg, per bottle of 60 tablets
S0108 Mercaptopurine, oral, 50 mg
S0109 Methadone, oral, 5 mg
S0117 Tretinoin, topical, 5 grams
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)
S0122 Injection, menotropins, 75 iu
S0126 Injection, follitropin alfa, 75 iu
S0128 Injection, follitropin beta, 75 iu
S0132 Injection, ganirelix acetate, 250 mcg
S0136 Clozapine, 25 mg
S0138 Finasteride, 5 mg
S0139 Minoxidil, 10 mg
S0140 Saquinavir, 200 mg
S0142 Colistimethate sodium, inhalation solution administered through dme, concentrated form, per mg
S0145 Injection, pegylated interferon alfa-2a, 180 mcg per ml
S0148 Injection, pegylated interferon alfa-2b, 10 mcg
S0155 Sterile dilutant for epoprostenol, 50 ml
S0156 Exemestane, 25 mg
S0157 Becaplermin gel 0.01%, 0.5 gm